ARPM and others review medicines advertising in Russia

At a special session of Russia’s National Advertising Forum-2017, titled “Those who must not be named: advertising of pharmaceutical products, prohibitions and opportunities,” the principles of inter-industry self-regulation in the field of medicine advertising were discussed.

Experts of the Association of the Russian Pharmaceutical Manufacturers, the Association of International Pharmaceutical Manufacturers (AIPM) and other professional Associations, the Association of Communication Agencies of Russia, the representatives of the Federal Antimonopoly Service (FAS), the State Duma (Parliament), as well as experts in a field of pharmaceutical industry advertising discussed the issue of advertising medicines, and the direction of effective interaction of regulators, the pharmaceutical and advertising industry with the purpose of providing the consumer with qualitative advertising content.

In 2017, FAS Russia instituted more than 25 cases on advertising medicines, which used the word “fast” or derivatives from it, because of violation of Paragraph 8 of Part 1 of the Federal Law № 38-FL of 13.03.2006 “About Advertising.” The AIPM’s executive director Vladimir Shipkovemphasized that the pharmaceutical and advertising industries are ready to take part of responsibility and together with the regulators ensure the proper enforcement of advertising legislation in the future.